Mitchell Todd Saltzberg MD Curriculum Vitae CV

20 Pages·2017·0.05 MB·English

Date of Document: April 6, 2019
CURRICULUM VITAE
Mitchell Todd Saltzberg MD
Professor
Department of Medicine
Division of Cardiology
OFFICE ADDRESS:
The Hub for Collaborative Medicine
8701 Watertown Plank Road
Milwaukee, WI 53226
EDUCATION:
- 12/1987 BS Graduate with Distinction, University of Wisconsin at Madison, Madison, WI
- 05/1992 MD, Yale University School of Medicine, New Haven, CT
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/1992 - 06/1995 Residency, Department of Internal Medicine, University of Chicago Hospital, Chicago, IL
07/1995 - 06/1998 Cardiology Fellowship, Cardiology, Rush-Presbyterian St Luke's Medical Center,
Chicago, IL
FACULTY APPOINTMENTS:
2001 - 2007 Heart Failure and General Cardiologists, Midwest Heart Specialists, 3825 Highland Ave Tower
2, Suite 400, Downers Grove, IL
2001 - 2007 Co-Director, Pulmonary Hypertension Program, Midwest Heart Specialists, 3825 Highland Ave
Tower 2, Suite 400, Downers Grove, IL
2001 - 2007 Medical Director, Heart Failure Program, Midwest Heart Specialists, 3825 Highland Ave Tower
2 Suite 400, Downers Grove, IL
2001 - 2007 Medical Director, Echocardiographic Core Laboratory, Midwest Heart Specialists, 3825
Highland Ave Tower 2, Suite 400, Downers Grove, IL
2007 - 08/2016 Medical Director, Heart Failure and Mechanical Circulatory Assist Program, Christiana Care
Health Services, 755 Ogletown-Stanton Road Suite 2E99, Newark, DE
09/2016 - Present Medical DIrector, Advanced Heart Failure, Medical College of Wisconsin, 9200 W.
Wisconsin Suite 5100, Milwaukee, WI
Associate Professor, Medicine, Kimmel Medical College, Thomas Jefferson University, 1025 walnut Street
Suite 100, Philadelphia, PA
Assistant Professor, Medicine, 1725 West Harrison Street Suite 439 POB, Chicago, IL
Associate Director, Cardiomyopathy and Transplant Program, 1725 West Harrison Street Suite 439 POB,
Chicago, IL
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2007 - 08/2016 Program Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program,
Christiana Care Health Services, 4755 Ogletown-Stanton Road Suite 2E99, Newark, DE
RESEARCH ADMINISTRATIVE APPOINTMENTS:
01/1986 - 08/1988 Research Assisstant, Cardiology, University of Wisconsin School of Medicine, Madison,
1 / 20
WI
05/1989 - 08/1989 Research Assistant, Cardiothoracic Surgery, Yale University School of Medicine, New
Haven, CT
10/1990 - 05/1992 Research Assistant, Nuclear Cardiology, Yale University School of Medicine, New Haven,
CT
11/2009 - 08/2016 Clinical Director, Clinical Research Center, Christiana Care Health System, Newark, DE
HOSPITAL STAFF PRIVILEGES:
09/2016 - Present Staff Physician, Froedtert Memorial Lutheran Hospital, 9200 West Wisconsin Avenue,
Milwaukee, WI
SPECIALTY BOARDS AND CERTIFICATION:
Board Certified Issue Date Expiration
ABIM - Cardiology 2008 None
ABIM - Advanced Heart Failure & Transplant 2010 None
Cardiology
American Board of Internal Medicine None

Certificates Issued By Issue Date Expiration
ACLS None
CPR None

Licensure Number Issue Date Expiration
Wisconsin License 2016 None

AWARDS AND HONORS:
- 1991 Long Term Reserach Fellowship, Connecticfut AHA
- 05/1992 First Place Award - Basic Science
- 2015 Certification in Heart Failure, Joint Commission Disease Specific
- 2008 Get with the Guidelines Bronze Award
- 1986 Phi Kappa Phi Honor Society
- 1989 Yale Summer Research Fellowship
- 2013 VAD Program Disease Specific Certification
- 1987 Golden Key Honor Society
- 1987 Phi Beta Kappa Honor Society
- 09/1996 Cardiovascular Meeting Grant, Genetech/AHA/ACC
- 2012 Get with the Guidelines Gold Award
- 05/1999 Hero of the Heart, Award for Humanitarian Care, Department of Religion Health & Human Values
- 2009 Resident Teaching Award
- 2013 Certification in Heart Failure, Joint Commission Disease Specific
- 1990 Short Term Research Fellowship, Yale Medical School
- 2015 VAD Program Disease Specific Certification
- 2011 VAD Program Development and Launch
- 2011 Resident Teaching Award
- 2011 Certification in Heart Failure, Joint Commission Disease Specific
- 2013 Get with the Guidelines Gold Plus Award, Jefferson Regional Clinical Center for Heart Failure
Network
- 2011 Get with the Guidelines Gold Award
- 2015 Get with the Guidelines Gold Plus Award, Jefferson Regional Clinical Center for Heart Failure
2 / 20
Network
- 1985 Phi Eta Sigma Honor Society
- 2009 Get with the Guidelines Silver Award
- 2014 Get with the Guidelines Gold Plus Award, Jefferson Regional Clinical Center for Heart Failure
Network
- 2010 Get with the Guidelines Gold Award
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
American Heart Association
American College of Cardiology
American Association of Heart Failure Nurses
Heart Failure Society of America
International Society for Heart & Lung Transplantation
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
1998 - Present Journal of Heart and Lung Transplantation
2005 - Present Journal of Cardiac Failure
2008 - Present Circulation
2009 - Present Journal of the American College of Cardiology
2009 - Present American Journal of Cardiology
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2001 - 2006 Member, National Heart Failure Committee, ACC
2011 - 2014 Member, Education Committee, HFSA
2014 - 2016 Member, Membership Committee, HFSA
Chair, Pharmacy and Therapeutics Medication Value Committee
Chair, Heart Failure Medicare Bundles Project at CCHS
Abstract Reviewer, AHA
Chair, Ventricular Assist Device Multidisciplinary Committee
Abstract Reviewer, HFSA
Chair, Heart Failure Multidisciplinary Committee
Chair, Membership Committee, Heart Failure Society of America
Abstract Reviewer, ACC
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
03/2002 - 03/2008 Member, National Heart Failure the Transplantation Committee, American College of
Cardiology
07/2006 - 06/2007 Member, IRB, Advocate Health System
09/2008 - Present Member, Education Committee, Heart Failure Society of America
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title: FIGHT Trial
Source: NIH Heart Failure Network 2.0 Clinical Trials
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: 2012 - 2019

Title: IRON-OUT Trial
3 / 20
Source: NIH Heart Failure Network 2.0 Clinical Trials
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: 2012 - 2019

Title: RED-ROSE Trial
Source: NIH Heart Failure Network 2.0 Clinical Trials
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: 2012 - 2019

Title: EXACT Trial
Source: NIH Heart Failure Network 2.0 Clinical Trials
Role: Principal Investigator
PI: Mitch Saltzberg
Dates: 2012 - 2019

Title: ROSE Trial
Source: NIH Heart Failure Network 2.0 Clinical Trials
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: 2012 - 2019

Title: ATHENA Trial
Source: NIH Heart Failure Network 2.0 Clinical Trials
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: 2012 - 2019

Prior
Peer Review
Title: A double-blind randomized placebo-controlled study to assess the effects
of Ro47-0203 (Bosentan) on the morbidity and mortality of patients with
chronic heart failure
Source: Actelion Ltd.
Role: Co-Investigator
Dates: - 1999

Title: Multicenter double-blind randomzied placebo-controlled, phase II/III
study of the effect of recombinant human tumor necrosis factor recepto
(p75) Fc fusnion protein (Etanercept) (TNFR:Fc) on clinical improvement
in patients with chronic heart failure (RENAISSANC) Protocol 016,0021
Role: Co-Investigator
Dates: - 1999

Title: Peerless Trial
Source: Paracor, Inc.
Role: Principal Investigator
PI: Mitichell Saltzberg
Dates: - 2008

Title: RED - HF Trial
Source: Amgen Corporation
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2006
4 / 20
Title: Multicenter, Randomized Double Blind, Placebo-controlled Study to
Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in
Subjects Hospitalized with Worsening Congestive Heart Failure
(EVEREST)
Source: Otsuka Maryland Research Institute, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: RABBIT - Rapid Assessment of Bedside BNP in Treatment of Heart
Failure
Source: Biosite, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: PROSPECT - Predictors of Response to CRT
Source: Medtronic Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: SALACIA Trial (Tolvaptan)
Source: Otsuka
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2011

Title: RABBIT - Rapid Assessment of Bedside BNP in Treatment of Heart
Failure
Source: Biosite, Inc.
Role: Principal Investigator
PI: Mitchell Satlzberg
Dates: - 2003

Title: CHARM - Candesartan cilexetil in heart failure assessment of reduction
mortality and morbidity
Source: Astra Hassle
Role: Co-Investigator
Dates: - 1999

Title: A Souble-blind, parallel-group, multi-center randomized placebo-
controlled study to assess the efficacy (symptomatology) and safety of
Ro61-0612 (tezosentan in patients with acute decompensated heart failure
Source: Actelion Ltd. and Hesperion Ltd.
Role: Co-Investigator
Dates: - 1999

Title: A two-year randomized, multicenter, double-blind study of the efficacy
and safety of SDZ RAD vs azathioprine as part of a triple
immunosuppressive therapy regimen in de novo heart transplant recipients
Source: Novartis Pharma AG
Role: Co-Investigator
Dates: - 1998

Title: COPERNICUS - A multicenter, randomized double-blind
5 / 20
placebo-controlled study to determine the effect of carvedilol on mortality
in patients with severe congestive heart failure
Source: Boehringer Mannheim GmbH (MF4477/SB287)
Role: Co-Investigator
Dates: - 1998

Title: A dose-ranging study to evaluate the safety and effectiveness of
intravenously administered TRK-820 in patients with hyponatremia
coincident with congestive heart failure (NYHA Class III-IV)
Source: Toray Industries Inc. (USTRK-2/01)
Role: Co-Investigator
Dates: - 1997

Title: Metroprolol CR/XL Randomized Intervention Trial in Congestive Heart
Failure-MERIT-HF, a double-blind, placebo controlled survival study
with Metoprolol CR/XL in patients with decreased ejection fraction and
symptoms of heart failure
Source: Astra
Role: Co-Investigator
Dates: - 1997

Title: CUPID - HF
Source: Celladon, Inc
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2013

Title: SERCA-2A, Gene Therapy Clinical Trial
Source: Celladon, Inc
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2013

Title: PITCH - HF, The Phosphodiesterase Type 5 Inhibition with Tadalafil
Changes Outcomes in Heart Failure Clinical Trial
Source: New England Research Institutes Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2013

Title: COSMIC-HF Clinical Trial
Source: Amgen, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2013

Title: Omecantiv Phase II Trial
Source: Amgen, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2011

Title: TEAM-UF Tiral (Investigator Initiated Study)
Source: Daxor, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2009
6 / 20
Title: Use of Intrathoracic Impedance Data to Improve Patient Self Care and
Quality of Life
Source: Investigator Initiated Study
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2009

Title: CY 112, Phase II
Source: Cytokinetics, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2008

Title: Cardiovascular Disease Screening in Patients Referred for Sleep Apnea
(SNORE)
Source: Guidant Corporation
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: FUSION II - Follow Up Serial Infusions of Natrecor (R) for the
Management of Patients with Heart Failure
Source: Scios, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: HART - Heart Failuyre Adherence & Retention Trial
Source: National Institute of Health
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2003

Title: A prospective trial of reduction ventriculectomy in patients with severe
heart failure (ORA#97011721)
Role: Co-Investigator
Dates: - 1998

Title: Multicenter, randomized, double-blind, placebo-controlled, oral
dose-defining, efficacy and safety study of OPC-41061 in patients with
extracellular volume expansion secondary to congestive heart failure
(E156-97-252)
Source: Otsuka America Pharmaceutical Inc.
Role: Co-Investigator
Dates: - 1998

Title: WCR System Pre-Market Approval Investigational Plan (Vest
Defibrillator)
Source: Lifecor, Inc.
Role: Co-Investigator
Dates: - 1998

Title: A Phase 3 randomized double-blind placebo controlled evaluation of the
onset and offset of hemodynamic effects of OPC-18790 (toborinone) in
patients with heart failure. Main Phase-Protocol #103-95-201
Source: Otsuka American Pharmaceutical, Inc.
7 / 20
Role: Co-Investigator
Dates: - 1998

Title: A Randomzied double-blind placebo-controlled, sequential-panel,
single-dose study to investigate the acute hemodynamic effects of IV
L-753, 037 (BQ 4508-2) in patients with symptomatic heart failure
(endothelin receptor antagonist)
Source: Merck & Co
Role: Co-Investigator
Dates: - 1998

Title: A randomized double-blind placebo-controlled study of two doses of
NATRECOR n-BNP administered as a continuous infusion in subjects
with decompensated congestive heart failure
Source: Scios Nova (704.311)
Role: Co-Investigator
Dates: - 1996

Title: Omecantiv Phase II Trial
Source: Amgen, Inc.
Dates: - 2011

Title: Hyponatremia Registry
Source: Otsuka
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2011

Title: Omecantiv Mercarbil, Phase I
Source: Amgen
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2010

Title: Team-HF Trial
Source: Daxor, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2010

Title: Ascend - HF
Source: Scios, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2007

Title: Improve - HF
Source: Medtronic, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2007

Title: REVEAL Registry
Source: Actelion Pharmaceuticals
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2006
8 / 20
Title: VISION Study
Source: Actelion Pharmaceuticals
Role: Principal Investigator
PI: Mitchell Satlzberg
Dates: - 2006

Title: Ultrafiltration vs IV Diuretics for Patients Hospitalized for Acute
Decompensated Congestive Heart Failure: A Prospective Randomized
Clinical Trial (UNLOAD)
Source: CHF Solutions, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2006

Title: Chronicle-ICD Trial
Source: Medtronic, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2006

Title: FIX-HF-5 Trial
Source: Impulse Dynamics
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2006

Title: ASSESS-HF, Assessing Cardiac Compass Trends for the Management of
Heart Failure Patients
Source: Medtronic
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: (REDHOT II) Rapid Emergency Department Heart Failure Out Patient
Trial
Source: Biosite, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2004

Title: EUPHORIA - Early Ultrafiltration THerapy in Patients with
Decompensated Heart Failure and Observed Resistance to Intervention
with Diuretic Agents
Source: Midwest Heart Foundation and CHF Solutions
Role: Co-Principal Investigator
Dates: - 2003

Title: STAMINA-HeFT Randomized Trial to Evaluate Darboepoeitin to
Improve Exercise Performance in Anemic Heart Failure Patients
Source: Amgen
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2002

Title: ESSENTIAL - The Studies of Oral Enoximone Therapy in Advanced
Heart Failure
9 / 20
Source: Myogen, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2001

Title: ADHERE - Acute Decompensated Heart Failure Registry
Source: Scios, Inc.
Role: Principal Investigator
PI: Mitchell Saltzberg
Dates: - 2001

Title: RENAIsSANCE - Randomized Etanercept North American Strategy to
Study Antagonism of Cytokines
Source: Immunex
Role: Co-Investigator
Dates: - 2000

Title: Chronical Implantable Hemodynamic Monitor for Patients with
Congestive Heart Failure
Source: Medtronic
Role: Co-Investigator
Dates: - 2000

Title: Study of the Hemodynamic and Clinical Effects of Natrecor (nesitride)
compared with Nitroglycerin Therapy of Symptomatic Decompensated
CHF
Source: Scios
Role: Co-Investigator
Dates: - 2000

Title: OVERTURE - Omapatrilat vs enalapril randomized trial of utility in
reducing events
Source: Bristol-Myers Squibb Pharmaceutical Research Institute
Role: Co-Investigator
Dates: - 1999

Title: ESCAPE - Evaluation study of congestive heart failure and pulmonary
artery catheterization effectiveness
Source: Duke Clinical Research Institute
Role: Co-Investigator
Dates: - 1999

Title: Natrecor (nesitiride) vs dobutamine therapy for symptomatic,
decompensated CHF: A Safety study using 24-hour Holter Monitoring
(#7040.329)
Source: Scios. Inc.
Role: Co-Investigator
Dates: - 1998

Title: IMPRESS - Inhibition of metallo-protease by MS-186716 in a randomized
exercise and symptoms study in subjects with heart failure
Source: Bristol-Myers Squibb
Role: Co-Investigator
Dates: - 1998

Title: Multicenter, randomized double-blind placebo-controlled parallel trial to
assess the effect of valsartan on exericse capacity, quality of flie, and signs
10 / 20